Sweden
· Delayed Price · Currency is SEK Bio-Works Technologies AB Statistics
Total Valuation
Bio-Works Technologies AB has a market cap or net worth of SEK 62.37 million. The enterprise value is 14.51 million.
| Market Cap | 62.37M |
| Enterprise Value | 14.51M |
Important Dates
The next estimated earnings date is Friday, February 21, 2025.
| Earnings Date | Feb 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio-Works Technologies AB has 77.96 million shares outstanding. The number of shares has increased by 13.57% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 77.96M |
| Shares Change (YoY) | +13.57% |
| Shares Change (QoQ) | +14.98% |
| Owned by Insiders (%) | 11.97% |
| Owned by Institutions (%) | 5.82% |
| Float | 59.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.85 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.39 |
| EV / Sales | 0.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.32 |
Financial Position
The company has a current ratio of 7.00
| Current Ratio | 7.00 |
| Quick Ratio | 5.66 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -280.45 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 1.08M |
| Profits Per Employee | -1.07M |
| Employee Count | 36 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.93% in the last 52 weeks. The beta is 1.18, so Bio-Works Technologies AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -88.93% |
| 50-Day Moving Average | 0.88 |
| 200-Day Moving Average | 2.08 |
| Relative Strength Index (RSI) | 37.31 |
| Average Volume (20 Days) | 36,156 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio-Works Technologies AB had revenue of SEK 37.88 million and -37.52 million in losses. Loss per share was -0.94.
| Revenue | 37.88M |
| Gross Profit | 27.72M |
| Operating Income | -39.82M |
| Pretax Income | -35.46M |
| Net Income | -37.52M |
| EBITDA | -39.12M |
| EBIT | -39.82M |
| Loss Per Share | -0.94 |
Balance Sheet
| Cash & Cash Equivalents | 47.86M |
| Total Debt | n/a |
| Net Cash | 47.86M |
| Net Cash Per Share | 0.61 |
| Equity (Book Value) | 57.64M |
| Book Value Per Share | 0.74 |
| Working Capital | 55.69M |
Cash Flow
In the last 12 months, operating cash flow was -44.96 million and capital expenditures -519,000, giving a free cash flow of -45.47 million.
| Operating Cash Flow | -44.96M |
| Capital Expenditures | -519,000 |
| Free Cash Flow | -45.47M |
| FCF Per Share | -0.58 |
Margins
Gross margin is 73.18%, with operating and profit margins of -105.13% and -99.05%.
| Gross Margin | 73.18% |
| Operating Margin | -105.13% |
| Pretax Margin | -93.62% |
| Profit Margin | -99.05% |
| EBITDA Margin | -103.26% |
| EBIT Margin | -105.13% |
| FCF Margin | n/a |
Dividends & Yields
Bio-Works Technologies AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.57% |
| Shareholder Yield | -13.57% |
| Earnings Yield | -117.12% |
| FCF Yield | -72.91% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bio-Works Technologies AB has an Altman Z-Score of 3.41.
| Altman Z-Score | 3.41 |
| Piotroski F-Score | n/a |